Skip to content
  • CAREERS
  • RFP

MLM ONLINE ®

Search
MLM Medical Labs
  • Meet MLM
    • About
    • Leadership
    • Global Reach Without Compromise
    • Quality / Accreditations & Certifications
    • MLM News and Insights
  • Services
    • Preclinical
      • Preclinical Services Overview
      • Cell Culture Modeling
      • In-Vivo Models
        • Fibrosis Models
    • Specialty Testing and Translational
      • Assay Development and Validation
      • Harmonized Flow Cytometry
      • Biomarkers in Neurodegeneration Disease Detection
      • Cell & Gene Therapy and ATMP Services
      • Animal Nutritional Developmental Studies
      • Medical Device Support
    • Histology
      • Immunostaining IHC/IF
      • Digital Pathology
      • Histology Image Gallery
    • Central lab services
      • Central Lab Overview
      • Safety Lab Testing
      • Study Set Up
      • Sample Analysis
      • MLM Kit Building®
      • mlm online®
      • Data Management
      • Global Logistics
    • MLM Kit Building®
      • MLM Kit Building®
      • MLM Safeguard Box®
    • Sample processing and Management
      • Global Access to High-Quality PBMCs
      • Point of Collection Tracking
  • Analytical Overview
    • Immunoassays
    • Platelet Function Assays
    • Multiplex Assays
    • Enzymatic Assays
    • Coagulation
    • Flow Cytometry
    • RT-PCR
    • HPLC
    • CELL-BASED Assays
    • Histology
  • Assay Menu
  • Resources
    • Knowledge Library
    • Unit Converter
    • Histology Image Gallery
  • Contact
    • Contact Us
    • Request For Proposals
    • Your Feedback
    • Subscribe
    • Locations
  • CAREERS
  • RFP

MLM ONLINE ®

Search
MLM Medical Labs
  • Meet MLM
    • About
    • Leadership
    • Global Reach Without Compromise
    • Quality / Accreditations & Certifications
    • MLM News and Insights
  • Services
    • Preclinical
      • Preclinical Services Overview
      • Cell Culture Modeling
      • In-Vivo Models
        • Fibrosis Models
    • Specialty Testing and Translational
      • Assay Development and Validation
      • Harmonized Flow Cytometry
      • Biomarkers in Neurodegeneration Disease Detection
      • Cell & Gene Therapy and ATMP Services
      • Animal Nutritional Developmental Studies
      • Medical Device Support
    • Histology
      • Immunostaining IHC/IF
      • Digital Pathology
      • Histology Image Gallery
    • Central lab services
      • Central Lab Overview
      • Safety Lab Testing
      • Study Set Up
      • Sample Analysis
      • MLM Kit Building®
      • mlm online®
      • Data Management
      • Global Logistics
    • MLM Kit Building®
      • MLM Kit Building®
      • MLM Safeguard Box®
    • Sample processing and Management
      • Global Access to High-Quality PBMCs
      • Point of Collection Tracking
  • Analytical Overview
    • Immunoassays
    • Platelet Function Assays
    • Multiplex Assays
    • Enzymatic Assays
    • Coagulation
    • Flow Cytometry
    • RT-PCR
    • HPLC
    • CELL-BASED Assays
    • Histology
  • Assay Menu
  • Resources
    • Knowledge Library
    • Unit Converter
    • Histology Image Gallery
  • Contact
    • Contact Us
    • Request For Proposals
    • Your Feedback
    • Subscribe
    • Locations

Clinical Insights

LPS-induced acture lung injury modell

 

Targeting the IRE1α/XBP1 Axis: A Novel Approach in ALI Treatment

Based on findings published in 2024 on Biomedical Central  ( 👉 read the study )

by Katie Dineen, B.S. Biology, Business Development Manager, Preclinical Research Services

Acute lung injury (ALI) and its more severe form, acute respiratory distress syndrome (ARDS), are life-threatening conditions that continue to challenge physicians worldwide. Despite decades of research, targeted therapies remain elusive—leaving a critical unmet need in respiratory medicine.

Recent studies have highlighted the significance of endoplasmic reticulum (ER) stress in the pathogenesis of ALI. The IRE1α/XBP1 signaling pathway, a key branch of the unfolded protein response (UPR), has been implicated in mediating inflammatory responses and apoptosis in lung tissues.

A recent study published in Respiratory Research explored the impact of modulating ER stress via the IRE1α/XBP1 pathway—an arm of the unfolded protein response known to exacerbate inflammation and apoptosis in lung tissues. Using a lipopolysaccharide (LPS)-induced ALI mouse model, researchers demonstrated that 4µ8C, a small molecule inhibitor of IRE1α, significantly attenuated lung inflammation, reduced pro-inflammatory cytokines (IL-6, IL-1β, TNF-α), and suppressed key inflammatory pathways such as TXNIP/NLRP3 and ERK/p65. Importantly, epithelial cell death was also mitigated, highlighting the pathway’s therapeutic potential.

These findings point to a promising new direction for treating acute lung injury (ALI). By blocking the IRE1α/XBP1 pathway, researchers were able to reduce harmful inflammation and cell damage in the lungs—key drivers of disease in ALI and ARDS. This opens the door to potential new treatments that focus on calming the body’s overactive stress responses during lung injury.

At MLM Medical Labs, we offer an established LPS-induced ALI model that closely mirrors key pathological features seen in human lung injury.

Leveraging this model, sponsors can rapidly evaluate novel mechanisms—like IRE1α/XBP1 inhibition—under rigorous, reproducible conditions. With scientific oversight from PhD-led project teams and robust in vivo infrastructure​, MLM enables preclinical insights that de-risk and accelerate respiratory drug development.

For those wanting to dive deeper into the research behind these findings, the full study is available 👉 HERE.

To learn more about working with MLM’s validated and customizable preclinical disease models, reach out to our team directly:

REACH MLM PRECLINICAL RESEARCH SERVICES
All Categories
Brochures
Clinical Insights
News and Events
Press Releases
Scientific Publications
Videos

RECENT INSIGHTS

CD4/CD8 Duplex Immunofluorescence : High-Resolution Immune Profiling from a Single Slide

Read now »

Managing PBMC Complexity in Global Immuno-Oncology Trials

Read now »

Power Your Oncology & Immunology Trials with AI-Enhanced Histopathology

Read now »

MLM Medical Labs – Germany Awarded 6th Consecutive CAP Accreditation for Service Excellence

Read now »

MLM Medical Labs Appoints Paul Kirchgraber, MD, MBA to Board of Directors

Read now »
Subscribe to mlm newsletter

Share this:

Share this:

Facebook
X
LinkedIn
Post navigation
← Previous Post
Next Post →

© 2025 MLM Medical Labs

  • Editorial Information
  • Privacy Policy
Subscribe to mlm newsletter